NCT01737684 A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013) Status COMPLETED Phase PHASE1
NCT01729819 Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women Status COMPLETED Phase PHASE2
NCT01663181 Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study Status COMPLETED Phase N/A
NCT01657409 Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome Status COMPLETED Phase PHASE2
NCT01644409 Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up Status COMPLETED Phase N/A
NCT01628042 A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014) Status COMPLETED Phase PHASE1
NCT01605617 Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate Status TERMINATED Phase PHASE4
NCT01578304 Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder Status COMPLETED Phase PHASE4
NCT01540786 An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics Status TERMINATED Phase PHASE1
NCT01539707 Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder Status COMPLETED Phase PHASE1
NCT01533597 The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB) Status COMPLETED Phase PHASE4
NCT01515722 Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder Status COMPLETED Phase NA
NCT01512004 Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder Status COMPLETED Phase PHASE3
NCT01500382 A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004) Status TERMINATED Phase PHASE1
NCT01499069 Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients Status COMPLETED Phase NA